Keywords
papillary carcinoma
thyroidectomy
central neck dissection
loco-regional recurrences
phonation abnormalities
ionized calcium levels
How to Cite
Abstract
Abstract. Prophylactic central lymph node dissection (PCLND) of the neck for papillary thyroid carcinomas (PTC) is one of the widely discussed issues, on which there is still no consensus. Most researchers discuss the range of indications for PCLND, recognizing that along with increased oncologic radicality, it increases the risk of postoperative hypoparathyroidism and phonation disorders.
The aim. To evaluate the outcomes of PCLND performance in PTC according to hospital registry data.
Material and methods. To assess the effectiveness of PCLND, all surgeries performed between 2015 and 2023 in patients with PTC were analyzed. All cases of cN0 and thyroidectomy (TE) only and TE+PCLND (1781 and 801 cases, respectively) were selected. Reoperations for disease progression were analyzed by comparing groups using Pearson’s χ² (mean follow-up 1.9 years). To analyze postoperative changes in phonation, a patient questionnaire was used. All cases of TE and TE+PCLND (1785 questions) were analyzed, and the comparison was also performed using Pearson’s χ² method. To assess the level of ionized calcium the day after surgery, the means were compared by t-test method and Fisher’s F-test (550 patients in total).
Results. When analyzing reoperations in the entire group with a mean follow-up period of 1.9 years, no statistically significant difference was found between TE and TE+PCLND (p>0.05). Limiting the group to a follow-up period from 1 to 5 years (mean follow-up period 2.6 years) does not change the situation: 2.1% of reoperations for TE and 3% for TE+PCLND (p>0.05). According to the questionnaire data on phonation changes (total 1785 questions), it was revealed that after only TE, 55.2% of patients had complaints, whereas after TE+PCLND they were 60.2% (p<0.05). If we do not take into account the minimal complaint of minor voice hoarseness, the statistical significance of the differences becomes even more confident: p<0.001 (13.7% vs. 20.4%). Postoperative ionized calcium levels also had statistically significant differences between groups (for TE mean 1.15; for TE+PCLND mean 1.13). Comparison of means by the t-test method yielded p<0.001, and by Fisher’s test p<0.05.
Conclusions. According to our hospital registry, performing PCLND for PTC does not result in a reduction in the percentage of reoperation but is associated with a higher percentage of phonation complaints and statistically significantly lower ionized calcium levels in the first day after surgery.
References
Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W, et al. The American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults. **Ann Surg.** 2020 Mar;271(3):e21-e93. doi:10.1097/SLA.0000000000003580.
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. **Thyroid.** 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
Luster M, Aktolun C, Amendoeira I, Barczyński M, Bible KC, Duntas LH, et al. European perspective on 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: proceedings of an Interactive International Symposium. **Thyroid.** 2019 Jan;29(1):7-26. doi: 10.1089/thy.2017.0129.
Calò PG, Lombardi CP, Podda F, Sessa L, Santini L, Conzo G. Role of prophylactic central neck dissection in clinically node-negative differentiated thyroid cancer: assessment of the risk of regional recurrence. **Updates Surg.** 2017 Jun;69(2):241-8. doi: 10.1007/s13304-017-0438-8.
Canu GL, Medas F, Conzo G, Boi F, Amato G, Erdas E, et al. Is prophylactic central neck dissection justified in patients with cN0 differentiated thyroid carcinoma? An overview of the most recent literature and latest guidelines. **Ann Ital Chir.** 2020;91:451-7.
Grišić K, Bumber B, Ćurić Radivojević R, Leović D. Prophylactic central neck dissection in well-differentiated thyroid cancer. **Acta Clin Croat.** 2020 Jun;59(Suppl 1):87-95. doi: 10.20471/acc.2020.59.s1.11.
Pavlidis ET, Pavlidis TE. Role of prophylactic central neck lymph node dissection for papillary thyroid carcinoma in the era of de-escalation. **World J Clin Oncol.** 2023 Jul 24;14(7):247-58. doi: 10.5306/wjco.v14.i7.247.
Xuan HN, Anh NX, Thuan NN, Thai DP, Le Van Q. Occult central lymph node metastasis in cN0 papillary thyroid carcinoma after robotic and TOETVA procedure. **J Thyroid Res.** 2023 Nov 30;2023:4779409. doi: 10.1155/2023/4779409.
Campana FP, Tartaglia E, Nunziata A, Izo G, Siciliano G, Cavallo F, et al. Clinical significance of prophylactic central neck dissection in the treatment of clinically node-negative differentiated thyroid cancer patients. **World J Surg Oncol.** 2023 May 11;21:247. doi: 10.1186/s12957-023-03018-5.
Zhong X, Lu Y, Yin X, Wang Q, Wang F, He Z. Prophylactic central neck dissection performed selectively with cN0 papillary thyroid carcinoma according to a risk-scoring model. **Gland Surg.** 2022 Feb;11(2):378-88. doi: 10.21037/gs-21-906.